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We suggest that the vertebrate myosin-I field adopt a
common nomenclature system based on the names
adopted by the Human Genome Organization (HUGO).
At present, the myosin-I nomenclature is very confusing;
not only are several systems in use, but several different
genes have been given the same name. Despite their
faults, we believe that the names adopted by the HUGO
nomenclature group for genome annotation are the best
compromise, and we recommend universal adoption.
 






















; the corresponding protein
































Myo1h. Although these names do not reflect the subclass
































 are most closely related; Fig. 1), this system
names all myosin-I genes and their protein products and is
presently being used to annotate the human and mouse
genomes. The HUGO names are reconciled with other
naming systems used for myosin-I gene products in Table I.
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Figure 1. Tree for human myosin-I 
genes. From Berg et al. (2001). Two 
recently predicted myosin-I genes are 
italicized, with the gene names 
suggested for them indicated in brackets.
 
We recommend those working with other vertebrates adopt
the mouse names (upper case for the first letter, lower case for
the rest), if appropriate modifying the gene or protein name

















). For example, myr 1—a rat




 Myo1b (or just Myo1b).
To provide continuity with the previous literature, we
suggest that common names be mentioned the first time
that the gene or protein is mentioned; after that point, how-
ever, only the systematic name should be used.
Finally, although we have focused on the myosin-I family,
we recommend that those working on other myosin families













Reconciliation of myosin-I names in the literature
























































Table adapted from Berg et al. (2001). 
